Top Ophthalmology Journal, Translational Vision Science & Technology, Approves Publication of Our Virtual Reality (VR) Clinical Trial

VR Clinical Trial Just Approved for Publication in Top Ophthalmology Journal!

We are excited to announce that our team's first clinical trial has been accepted for publication in Translational Vision Science & Technology, a top ophthalmology journal. In this study, we demonstrated the feasibility of using virtual reality for the rapid detection of eyelid droop, including several advantages to using a more portable, accelerated system. This milestone demonstrates yet another way virtual reality technologies can transform the vision care landscape, particularly with novel algorithms like the one used in this study. We look forward to keeping you updated with more clinical results as they emerge!

Previous
Previous

7 Reasons Why We Invented OcuVue™

Next
Next

Big Things Happening this Year for Retina Technologies at AAO 2022!